For research use only. Not for therapeutic Use.
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine[1].
| Catalog Number | I043757 |
| CAS Number | 1582205-90-0 |
| Purity | ≥95% |
| Reference | [1]. Goadsby PJ, Reuter U, Hallström Y, et al. A Controlled Trial of Erenumab for Episodic Migraine. N Engl J Med. 2017;377(22):2123-2132. |
